Cancer Immunotherapy: Silencing Intracellular Negative Immune Regulators of Dendritic Cells
Dendritic cells (DCs) are capable of activating adaptive immune responses, or inducing immune suppression or tolerance. In the tumor microenvironment, the function of DCs is polarized into immune suppression that attenuates the effect of T cells, promoting differentiation of regulatory T cells and s...
Main Authors: | Yao-Hua Liu, I-Jeng Yeh, Ming-Derg Lai, Kuan-Ting Liu, Po-Lin Kuo, Meng-Chi Yen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-01-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/11/1/108 |
Similar Items
-
RNA interference is ineffective as a routine method for gene silencing in chick embryos as monitored by <italic>fgf8</italic> silencing
Published: (2005-01-01) -
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers
by: Md. Emranul Karim, et al.
Published: (2018-05-01) -
Delivery of RNAi Therapeutics to the Airways—From Bench to Bedside
by: Yingshan Qiu, et al.
Published: (2016-09-01) -
Basic Principles of RNA Interference: Nucleic Acid Types and In Vitro Intracellular Delivery Methods
by: Marie Isenmann, et al.
Published: (2023-06-01) -
RNA Interference as a Prospective Tool for the Control of Human Viral Infections
by: Alesia Levanova, et al.
Published: (2018-09-01)